PRS59 - The Impact on Long-Term Targeted Therapy with Omalizumab on The Quality of Life According To Registry of Children with Uncontrolled Severe Persistent Asthma (Russian Experience)

Autor: Namazova-Baranova, L, Vishneva, E, Dobrynina, E, Alekseeva, A, Levina, J, Efendieva, K, Smirnov, V, Antonova, E, Voznesenskaya, N, Selimzianova, L
Zdroj: In Value in Health November 2016 19(7):A559-A559
Databáze: ScienceDirect